- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 3 x ZGS: [(2~{R})-2-oxidanyl-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-propyl] (9~{Z},12~{Z},15~{Z})-octadeca-9,12,15-trienoate(Non-covalent)
- 17 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
LMT.4: 10 residues within 4Å:- Chain A: L.188, I.189, A.192, Q.196, N.323, D.324, Q.326, N.327, L.330
- Ligands: LMT.5
Ligand excluded by PLIPLMT.5: 7 residues within 4Å:- Chain A: I.189, I.193, Q.196, I.197, M.200
- Ligands: LMT.4, LMT.6
Ligand excluded by PLIPLMT.6: 11 residues within 4Å:- Chain A: I.193, I.197, A.201, D.234, A.238, I.241, V.245, I.249
- Ligands: LMT.5, LMT.10, LMT.11
Ligand excluded by PLIPLMT.7: 10 residues within 4Å:- Chain A: V.120, L.121, F.124, L.125, Y.128, P.130, S.131, V.132, W.139
- Ligands: LMT.15
Ligand excluded by PLIPLMT.8: 12 residues within 4Å:- Chain A: D.71, F.73, Y.74, I.77, F.80, V.81
- Chain B: Y.48, K.54
- Chain C: L.97, F.102, P.104
- Ligands: LMT.17
Ligand excluded by PLIPLMT.9: 11 residues within 4Å:- Chain A: S.438, V.441, S.442, S.445, F.448, E.461, L.464, T.465, I.468, L.469, A.473
Ligand excluded by PLIPLMT.10: 15 residues within 4Å:- Chain A: K.39, L.40, A.47, I.51, S.174, A.177, Y.178, T.181, V.182, L.185, I.189, I.249
- Ligands: LMT.6, LMT.11, LMT.20
Ligand excluded by PLIPLMT.11: 5 residues within 4Å:- Chain A: V.36, L.40, Y.178
- Ligands: LMT.6, LMT.10
Ligand excluded by PLIPLMT.12: 7 residues within 4Å:- Chain A: C.37, S.38, C.41, V.255, V.256, L.259, G.260
Ligand excluded by PLIPLMT.13: 8 residues within 4Å:- Chain A: P.101, W.102, T.103, W.111, L.114, S.115, L.150
- Ligands: LMT.14
Ligand excluded by PLIPLMT.14: 9 residues within 4Å:- Chain A: L.96, R.99, T.100, P.101, W.111, T.149, L.150, C.153
- Ligands: LMT.13
Ligand excluded by PLIPLMT.15: 7 residues within 4Å:- Chain A: L.125, Q.134, G.135, V.138, W.139, F.143
- Ligands: LMT.7
Ligand excluded by PLIPLMT.16: 10 residues within 4Å:- Chain A: Y.128, S.131, Q.233, N.237, M.240, I.241, G.244, V.245, A.248
- Chain B: A.65
Ligand excluded by PLIPLMT.17: 6 residues within 4Å:- Chain A: Y.74, G.135, V.137, L.141
- Ligands: LMT.8, LMT.18
Ligand excluded by PLIPLMT.18: 6 residues within 4Å:- Chain A: W.85, V.138, I.142, C.145, C.146
- Ligands: LMT.17
Ligand excluded by PLIPLMT.19: 8 residues within 4Å:- Chain A: I.368, V.371, G.460, K.463, L.464, K.467, S.471, I.475
Ligand excluded by PLIPLMT.20: 5 residues within 4Å:- Chain A: C.37, L.40, I.44, V.252
- Ligands: LMT.10
Ligand excluded by PLIP- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nguyen, C. et al., Lipid flipping in the omega-3 fatty-acid transporter. Nat Commun (2023)
- Release Date
- 2023-05-10
- Peptides
- Sodium-dependent lysophosphatidylcholine symporter 1-B: A
FAB light chain: B
FAB heavy chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 3 x ZGS: [(2~{R})-2-oxidanyl-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-propyl] (9~{Z},12~{Z},15~{Z})-octadeca-9,12,15-trienoate(Non-covalent)
- 17 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nguyen, C. et al., Lipid flipping in the omega-3 fatty-acid transporter. Nat Commun (2023)
- Release Date
- 2023-05-10
- Peptides
- Sodium-dependent lysophosphatidylcholine symporter 1-B: A
FAB light chain: B
FAB heavy chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.